Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-03-02

Clinical Trial Update: Lifestyle Interventions to Reduce Diabetes Risk [NA]

View source ↗

Summary

This update reports on a completed NIDDK clinical trial assessing whether lifestyle interventions can reduce the risk of progressing from impaired glucose toler…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Glucose Intolerance, Diabetes Mellitus, Type 2 | NA | Status: COMPLETED